Rosuvastatin Calcium
Pediatric use information for patients 7 to 17 years of age is approved for AstraZeneca’s CRESTOR (rosuvastatin calcium) tablets. However, due to AstraZeneca’s marketing exclusivity…
Medications Updated During November 2019, From Newest to Oldest, Page 2
Ezetimibe and Simvastatin
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease…
Dexmethylphenidate Hydrochloride
Dexmethylphenidate hydrochloride tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies (14)]. Dexmethylphenidate hydrochloride…
Banzel (Rufinamide)
BANZEL is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults. BANZEL is indicated for…
Namenda XR (Memantine Hydrochloride)
NAMENDA XR is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. NAMENDA XR is a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the…